JANSSEN] R&D, CLINICAL DEVELOPMENT IMMUNOLOGY TA, CLINICAL LEAD

About Johnson & Johnson At Johnson & Johnson,  we believe health is everything.
Our strength in healthcare innovation empowers us to build a  world where complex diseases are prevented, treated, and cured,  where treatments are smarter and less invasive, and  solutions are personal.
Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Learn more at https://www.
nj.
om/.
•Japan Clinical Lead is responsible for development and execution of clinical development strategy for target indication in assigned compound to obtain regulatory approval in Japan Based on the Japan clinical development plan in alignment with global development strategy, Japan Clinical Lead is responsible for planning/execution/reporting of clinical studies and health authority interactions on clinical matters Responsibilities for clinical development strategy in Japan Develops clinical development strategy of target indication which fulfills Target Product Profile (TPP)/target label and target New Drug Application (NDA) submission timeline.
Develops clinical data package, designs local/regional studies or selects Global studies constituting the clinical data package.
Responsibilities in Global study •Reviews study plan and design [i.
.
Protocol Element Document (PED)/protocol(s) or any relevant study design information].
•Assess clinical feasibility with local medical needs for Japan participation.
Provides input to global clinical team (CT) and compound development team (CDT).
•Request to create local amendment if needed to fulfil Japanese medical and regulatory needs.
•Develops clinical section on Clinical Trial Notification (CTN) and responds to clinical related queries from PMDA •Partners with clinical operations for study setup and execution to ensure that the study is executed according to the protocol and required Japanese data can be obtained.
•Reviews study related documents including Japanese translated Investigator’s brochure (IB) and Informed Consent Form (ICF) with clinical and scientific point of view.
•Participates in Clinical Functional Trial Team (CFTT) meeting or other relevant venue (detail tbd) for each study as Japan representative and provides inputs from Japan perspectives •Provides medical monitoring support for Japanese participants if needed •Executes safety monitoring and assessment as one of core members of J-SMT Responsibilities in Local/regional study •Designs study and develops PED/protocol(s) •Establish Efficacy and/or Safety and/or Diagnosis Committee if needed •Reviews study related documents including Statistical Analysis Plan (SAP)/Data •Presentation Specification (DPS), materialsIDMC charter (if necessary), analytical riskbased monitoring plan, criteria of protocol deviation plan •Develops clinical section on Clinical Trial Notification (CTN) and respond to clinical related queries from PMDA •Partners with clinical operations for study setup and execution to ensure that the study is executed according to the protocol and required Japanese data can be obtained •Conducts medical monitoring with support from Study Responsible Physician and takes necessary measures such as amending the protocol to ensure subject safety and appropriate collection of clinical data.
•Executes safety monitoring and assessment as one of core members of J-SMT •Reviews top line results and interprets the clinical data •Leads development of Clinical Study Report (CSR) •Develops R&D publication plan with MAF and executes R&D publications based on the agreed R&D publication plan •Leads primary publication of clinical study data Responsibilities for health authority interaction Develops clinical section of Briefing Book for PMDA consultation(s) Develops clinical section of Common Technical Document (CTD) Generates responses to clinical inquiries from health authorities Generates documents for Orphan Drug Designation if applicable.
Prepares and responds tos PMDA’s inspection on protocol-related matters and supports clinical matters.
Supports development of Risk Management Plan and J-package insert by cross-functional team Supports pricing negotiation from clinical and/or scientific viewpoints Accountability for clinical data Accountable for interpretation of all clinical data at the levels of assigned indication(s) and/or compound(s) Presents scientific and clinical information, and leads clinical discussions with internal/external stakeholders including health authorities Responsibility for KOL management Identifies R&D related KOLs and appropriately communicates from clinical development viewpoints Qualifications 5 years of pharmaceutical industry experience overall including clinical study experience at least 3 years.
Thorough knowledge of drug development process is required Preferable to demonstrate leadership in two or more development programs which led to successful clinical study execution and/or registration in Japan Thorough understanding and compliance with healthcare regulations/guideline and ethics is critical.
Communication skill (oral and written) in both Japanese and English is critical Demonstrated ability to effectively collaborate across functional and global/regional boundaries are critical Sense of ownership, enterprise mindset and agility are required Planning, issue-solving skills for developing creative solutions and meeting project objectives are required Demonstrated ability of strategic thinking and contingency planning to manage ambiguity and make decisions with incomplete information are required Ability to survey and interpret the scientific literature related to the assigned projects is required